Urokinase-type Plasminogen Activator-like Proteases in Teleosts Lack Genuine Receptor-binding Epidermal Growth Factor-like Domains*

Background: In mammals, extracellular proteolysis initiated by urokinase-type plasminogen activator (uPA) is associated with cell surfaces via the uPA-receptor uPAR. Results: Fish have two uPAs, one lacking the uPAR-binding domain, another having a uPAR-binding domain lacking two cysteines and a genuine uPAR-binding sequence. Conclusion: In fish, uPA-dependent proteolysis occurs without uPAR. Significance: Evolutionary studies provide a more comprehensive understanding of extracellular proteolysis. Plasminogen activation catalyzed by urokinase-type plasminogen activator (uPA) plays an important role in normal and pathological tissue remodeling processes. Since its discovery in the mid-1980s, the cell membrane-anchored urokinase-type plasminogen activator receptor (uPAR) has been believed to be central to the functions of uPA, as uPA-catalyzed plasminogen activation activity appeared to be confined to cell surfaces through the binding of uPA to uPAR. However, a functional uPAR has so far only been identified in mammals. We have now cloned, recombinantly produced, and characterized two zebrafish proteases, zfuPA-a and zfuPA-b, which by several criteria are the fish orthologs of mammalian uPA. Thus, both proteases catalyze the activation of fish plasminogen efficiently and both proteases are inhibited rapidly by plasminogen activator inhibitor-1 (PAI-1). But zfuPA-a differs from mammalian uPA by lacking the exon encoding the uPAR-binding epidermal growth factor-like domain; zfuPA-b differs from mammalian uPA by lacking two cysteines of the epidermal growth factor-like domain and a uPAR-binding sequence comparable with that found in mammalian uPA. Accordingly, no zfuPA-b binding activity could be found in fish white blood cells or fish cell lines. We therefore propose that the current consensus of uPA-catalyzed plasminogen activation taking place on cell surfaces, derived from observations with mammals, is too narrow. Fish uPAs appear incapable of receptor binding in the manner known from mammals and uPA-catalyzed plasminogen activation in fish may occur mainly in solution. Studies with nonmammalian vertebrate species are needed to obtain a comprehensive understanding of the mechanism of plasminogen activation.

[1]  B. Furie,et al.  Structural Basis for Recognition of Urokinase-type Plasminogen Activator by Plasminogen Activator Inhibitor-1* , 2011, The Journal of Biological Chemistry.

[2]  María Martín,et al.  Ongoing and future developments at the Universal Protein Resource , 2010, Nucleic Acids Res..

[3]  J. Kjems,et al.  RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1. , 2010, Biochemistry.

[4]  Mingdong Huang,et al.  Structure-based Engineering of Species Selectivity in the Interaction between Urokinase and Its Receptor , 2010, The Journal of Biological Chemistry.

[5]  P. Andreasen,et al.  Nonproteolytic induction of catalytic activity into the single-chain form of urokinase-type plasminogen activator by dipeptides. , 2009, Biochemistry.

[6]  I. Rodriguez,et al.  Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors , 2009, Nature.

[7]  Nicholas H. Putnam,et al.  The amphioxus genome and the evolution of the chordate karyotype , 2008, Nature.

[8]  M. Ploug,et al.  Structure and ligand interactions of the urokinase receptor (uPAR). , 2008, Frontiers in bioscience : a journal and virtual library.

[9]  Y. Durocher,et al.  Transfection of HEK293-EBNA1 Cells in Suspension with Linear PEI for Production of Recombinant Proteins. , 2008, CSH protocols.

[10]  D. Shaw,et al.  Structural basis of interaction between urokinase-type plasminogen activator and its receptor. , 2006, Journal of molecular biology.

[11]  D. Dichek,et al.  Mechanisms of Cardiac Fibrosis Induced by Urokinase Plasminogen Activator* , 2006, Journal of Biological Chemistry.

[12]  D. Shaw,et al.  Structure of Human Urokinase Plasminogen Activator in Complex with Its Receptor , 2006, Science.

[13]  Torsten Schwede,et al.  BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .

[14]  J. Budczies,et al.  Gene expression patterns – a tool for bioanalysis , 2005 .

[15]  Joaquín Dopazo,et al.  PupasView: a visual tool for selecting suitable SNPs, with putative pathological effect in genes, for genotyping purposes , 2005, Nucleic Acids Res..

[16]  Lina L. Feng,et al.  Evolution of distinct EGF domains with specific functions , 2005, Protein science : a publication of the Protein Society.

[17]  Tatiana A. Tatusova,et al.  NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins , 2004, Nucleic Acids Res..

[18]  Charles E. Chapple,et al.  Genome duplication in the teleost fish Tetraodon nigroviridis reveals the early vertebrate proto-karyotype , 2004, Nature.

[19]  Robert C. Edgar,et al.  MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.

[20]  L. Lutter,et al.  Mutation of the highly conserved tryptophan in the serpin breach region alters the inhibitory mechanism of plasminogen activator inhibitor-1. , 2003, Biochemistry.

[21]  R. Doolittle,et al.  The evolution of vertebrate blood coagulation as viewed from a comparison of puffer fish and sea squirt genomes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Y. Durocher,et al.  High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. , 2002, Nucleic acids research.

[23]  D. Church,et al.  Spidey: a tool for mRNA-to-genomic alignments. , 2001, Genome research.

[24]  H. Wergeland,et al.  Studies of Atlantic salmon (Salmo salar L.) blood, spleen and head kidney leucocytes using specific monoclonal antibodies, immunohistochemistry and flow cytometry. , 2000, Fish & shellfish immunology.

[25]  P. Gettins,et al.  Serine 380 (P14) --> glutamate mutation activates antithrombin as an inhibitor of factor Xa. , 2000, The Journal of biological chemistry.

[26]  D. Collen The Plasminogen (Fibrinolytic) System , 1999, Thrombosis and Haemostasis.

[27]  D. Birnbaum,et al.  Ancient large-scale genome duplications: phylogenetic and linkage analyses shed light on chordate genome evolution. , 1998, Molecular biology and evolution.

[28]  R. Norton,et al.  Role of the 6‐20 disulfide bridge in the structure and activity of epidermal growth factor , 1998, Protein science : a publication of the Protein Society.

[29]  M. Ploug,et al.  Photoaffinity labeling of the human receptor for urokinase-type plasminogen activator using a decapeptide antagonist. Evidence for a composite ligand-binding site and a short interdomain separation. , 1998, Biochemistry.

[30]  P. Carmeliet,et al.  Receptor-independent Role of Urokinase-Type Plasminogen Activator in Pericellular Plasmin and Matrix Metalloproteinase Proteolysis during Vascular Wound Healing in Mice , 1998, The Journal of cell biology.

[31]  R. Overbeek,et al.  Searching for patterns in genomic data. , 1997, Trends in genetics : TIG.

[32]  M. Duffy,et al.  The urokinase‐type plasminogen activator system in cancer metastasis: A review , 1997, International journal of cancer.

[33]  K. Danø,et al.  Domain Interplay in the Urokinase Receptor , 1996, The Journal of Biological Chemistry.

[34]  S. Moestrup,et al.  The Multiligand α2‐Macroglobulin Receptor/Low Density Lipoprotein Receptor‐Related Protein (α2MR/LRP) , 1994 .

[35]  W. Driever,et al.  Characterization of a cell line derived from zebrafish (brachydanio rerio) embryos , 1993, In Vitro Cellular & Developmental Biology - Animal.

[36]  K. Danø,et al.  Diversity in catalytic properties of single chain and two chain tissue-type plasminogen activator , 1991 .

[37]  P. Andreasen,et al.  Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells. , 1990, Cell regulation.

[38]  F. Sallés,et al.  A plasminogen activator is induced during goldfish optic nerve regeneration. , 1990, The EMBO journal.

[39]  L. Lund,et al.  One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity. , 1988, The Journal of biological chemistry.

[40]  E. Appella,et al.  Structure and function of epidermal growth factor‐like regions in proteins , 1988, FEBS letters.

[41]  D. Belin,et al.  Amiloride selectively inhibits the urokinase‐type plasminogen activator , 1987, FEBS letters.

[42]  E. Appella,et al.  The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. , 1987, The Journal of biological chemistry.

[43]  Y. Wakamatsu,et al.  Fish plasminogen activators: their identification and characterization. , 1987, Cell structure and function.

[44]  G. Kaplan,et al.  Salmonid macrophages: separation, in vitro culture and characterization , 1981 .

[45]  D. Deutsch,et al.  Plasminogen: Purification from Human Plasma by Affinity Chromatography , 1970, Science.

[46]  P. Andreasen,et al.  Biochemical properties of plasminogen activator inhibitor-1. , 2009, Frontiers in bioscience.

[47]  R. Doolittle,et al.  Step-by-step evolution of vertebrate blood coagulation. , 2009, Cold Spring Harbor symposia on quantitative biology.

[48]  P. Carmeliet,et al.  Modification of kidney barrier function by the urokinase receptor , 2008, Nature Medicine.

[49]  R D Appel,et al.  Protein identification and analysis tools in the ExPASy server. , 1999, Methods in molecular biology.

[50]  P. Culp Random DNA integrations as an approach to insertional mutagenesis in the zebrafish (Brachydanio rerio) , 1994 .